111 Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
111 Capital's IDXX Position: Q2 2026 in Review
111 Capital increased its Idexx Laboratories (IDXX) stake by 18% in Q2 2026, buying an estimated $53.3K and bringing the position to 631 shares worth $332K. The position accounts for 0.06% of the portfolio, ranked #323.
111 Capital first reported a position in IDXX in Q4 2024 and has held it in 6 quarters since. The position peaked at $866K in Q4 2024. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- 111 Capital held 631 shares of Idexx Laboratories worth $332K as of Q2 2026.
- 111 Capital bought 95 Idexx Laboratories shares in Q2 2026, an estimated $53.3K.
- Idexx Laboratories made up 0.06% of 111 Capital's portfolio in Q2 2026, its #323 holding.
- 111 Capital first reported a position in Idexx Laboratories in Q4 2024 and has held it in 6 quarters since.
- 111 Capital's Idexx Laboratories position peaked at $866K in Q4 2024.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.